Peter Gray - Aug 18, 2022 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
Director
Signature
By: /s/Adam Guttmann, as attorney in fact For: Peter Gray
Stock symbol
JAZZ
Transactions as of
Aug 18, 2022
Transactions value $
-$821,760
Form type
4
Date filed
8/22/2022, 05:03 PM
Previous filing
Aug 9, 2022
Next filing
Aug 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Options Exercise $442K +8K +56.2% $55.28 22.2K Aug 18, 2022 Direct
transaction JAZZ Ordinary Shares Sale -$1.26M -8K -35.98% $158.00 14.2K Aug 18, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JAZZ Non-Qualified Stock Option (right to buy) Options Exercise $0 -8K -100% $0.00* 0 Aug 18, 2022 Ordinary Shares 8K $55.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan. Subject to the Reporting Person's continuous service and certain additional conditions, this option vested over three years from the Vesting Commencement Date, with 1/3 that vested on the first anniversary of the Vesting Commencement Date and the remainder vested in 24 equal monthly installments thereafter.